IL10 and B-cell chronic lymphocytic leukemia: 80% of patients that completed the study showed a reduction of circulating lymphocytes and Treg cells, usually increased in CLL, together with a drop of IL-10 and TGF-β serum levels; therefore, indicating a possibility of influence on circulating cells in CLL patients [108].